METTL3 and colorectal cancer: METTL3 depletion promotes STAT1 and IRF1 mRNA expression in an m6A-YTHDF2-dependent manner, which in turn improves immunotherapeutic response by modulation of tumor-infiltrating cells in the intratumor microenvironment of colorectal cancer [25].